A report offers a comprehensive benchmarking and assessment of pharmaceutical manufacturer engagement with specialty pharmacies.
When patients struggle to see a positive path forward, modeling a constructive journey can give them the confidence they need.
This serialization system represents a business imperative that yields significant competitive advantages.
These innovations are revolutionizing pharmaceutical packaging by enhancing drug safety, combating counterfeiting, ensuring regulatory compliance, and improving patient adherence across the supply chain.
Direct-to-consumer and direct-to-patient models are major contributors.
How can pharma manufacturers and distributors balance logistical demands and environmental impact?
Six steps pharma organizations can follow to help achieve sustainability in their product supply chains
Transitioning a rare disease HUB or NCP program to a rare-focused partner can yield major service quality improvements without program disruption.
How cross-functional commercialization teams can hone their role within clinical management pathways, communicate value to all stakeholders, achieve excellence in evidence generation, and maximize the opportunities of digital technologies
Companies striving for transformed and targeted growth are exploring strategies that include partnerships, artificial intelligence, increased efficiencies, and competitive intelligence.
Approaches powered by RWD can clear the way for a greater focus on patient-centered care.
Creating positive experiences and other patient-focused strategies for sponsors to consider when planning and executing cancer studies
This serialization system represents a business imperative that yields significant competitive advantages.
How biopharma commercial teams can leverage machine learning techniques to improve targeting of HCPs and patients
Sandra Anderson outlines what manufacturers need to know about the regulatory environment and commercialization solutions for the Canadian market.
Leaders from Janssen, Novartis Gene Therapies, Pierre Fabre, and the German cancer app start-up Mika discuss how they are leveraging data in innovative ways to advance their engagement with the scientific community and their overall commercial operations
Strategies to boost the reproducibility and traceability of cell and gene therapies for more effective clinical studies and commercialization
The importance of embracing universal values and business models that prioritize humanity.
Kevin Lynch, Vice President of Global Sales at QProducts & Services, dives into the role of sustainability in pharmaceutical packaging.
Exploring RCT, RWE and alternative study designs as a path forward
With today's pharmacy landscape shaken by unprecedented and wider disruption to healthcare support and delivery, community and independent entities strive to remain an integral cog in the mix.
Why it's critical for companies to set long-term, strategic goals in their journeys toward decarbonization.
How digital adoption is driving pharmacovigilance
A panel of industry leaders share key insights supporting the integration of patient-centric strategies into current and future drug development and market access efforts.
Why these programs require a hybrid approach that combines technology and human connection.
In this podcast, we speak with Amanda Scholz, UBC Senior Clinical Program Manager, MHA, BSN, RN as we discuss the important role that clinical adherence programs play in empowering patients and bolster persistence to prescribed life-changing medications throughout their journey.